Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-13

Clinical Trial Update: Influence of Administration Route of Testosterone on Male Fertility [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating whether the route of testosterone administration affects male fertility has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Hypogonadism | Phase 1 | Status: WITHDRAWN